These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4679879)

  • 1. A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects.
    Farrell PC; Grib NL; Fry DL; Popovich RP; Broviac JW; Babb AL
    Trans Am Soc Artif Intern Organs; 1972; 18(0):268-76, 281. PubMed ID: 4679879
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative solute transport and therapeutic effectiveness of multiple point support and standard Kiil hemodialyzers.
    Edson H; Keen M; Gotch F
    Trans Am Soc Artif Intern Organs; 1972; 18(0):113-21, 123. PubMed ID: 4679863
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes.
    Buoncristiani U; Galli F; Benedetti S; Errico R; Beninati S; Ghibelli L; Floridi A; Canestrari F
    Contrib Nephrol; 1999; 125():133-58. PubMed ID: 9895437
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrinology and metabolism in uremia and dialysis: a clinical review.
    Feldman HA; Singer I
    Medicine (Baltimore); 1975 Sep; 54(5):345-76. PubMed ID: 808679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug displacement from protein-binding and redistributional interactions.
    McQueen EG
    Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of protein bound substances in uremia.
    Vanholder R; De Smet R; Ringoir S
    ASAIO J; 1994; 40(1):90-2. PubMed ID: 8186501
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of dialysis membranes in elimination of uremic toxins].
    Grzeszczak W; Zukowska-Szczechowska E; Rutkowski B
    Przegl Lek; 1996; 53(5):439-42. PubMed ID: 8754410
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodialyzer evaluation by examination of solute molecular spectra.
    Babb AL; Farrell PC; Uvelli DA; Scribner BH
    Trans Am Soc Artif Intern Organs; 1972; 18(0):98-105, 122. PubMed ID: 4679922
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of plasma protein binding on renal clearance of drugs.
    Levy G
    J Pharm Sci; 1980 Apr; 69(4):482-3. PubMed ID: 7373556
    [No Abstract]   [Full Text] [Related]  

  • 10. Uraemic and normal plasma protein binding of various cardiac glycosides under "in vivo" conditions.
    Kramer P; Köthe E; Scheler F
    Eur J Clin Invest; 1974 Feb; 4(1):53-8. PubMed ID: 4819835
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo studies of a new ultrathin membrane for hemodialysis.
    Kjellstrand CM; Petersen RJ; Evans RL; Shideman JR; Santiago EA; Buselmeier TJ; Rozelle LT
    Trans Am Soc Artif Intern Organs; 1972; 18(0):106-12, 122-3. PubMed ID: 4679862
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum binding of methyltetrahydrofolic acid.
    Spector R; Lorenzo AV; Drum DE
    Biochem Pharmacol; 1975 Feb; 24(4):542-4. PubMed ID: 1167461
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of disease on binding of drugs to plasma proteins.
    Reidenberg MM; Affrime M
    Ann N Y Acad Sci; 1973 Nov; 226():115-26. PubMed ID: 4520390
    [No Abstract]   [Full Text] [Related]  

  • 14. Dialysis of methylguanidine.
    Giovannetti S; Barsotti G
    Kidney Int; 1974 Sep; 6(3):177-83. PubMed ID: 4425483
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of hippurate in normal plasma and in uremic plasma pre- and postdialysis.
    Farrell PC; Gotch FA; Peters JH; Berridge BJ; Lam M
    Nephron; 1978; 20(1):40-6. PubMed ID: 619299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding of thiopental in patients with impaired renal or hepatic function.
    Ghoneim MM; Pandya H
    Anesthesiology; 1975 May; 42(5):545-9. PubMed ID: 1130720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid and solute transfer characteristics in a dialyzer with a high-performance membrane.
    Mineshima M
    Contrib Nephrol; 2011; 173():103-109. PubMed ID: 21865782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdialysis sampling for determination of plasma protein binding of drugs.
    Herrera AM; Scott DO; Lunte CE
    Pharm Res; 1990 Oct; 7(10):1077-81. PubMed ID: 2281040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarity of the dialysance of endogenous aryl acids and O-iodohippurate (hippuran) in uremic man.
    Cohlmia JB; Whittier FC; Grantham JJ
    Proc Clin Dial Transplant Forum; 1974; (4):224-7. PubMed ID: 4468422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fixation of drugs on plasma proteins].
    Tillement JP; Houin G; Zini R; Urien S; Albengres E; Barré J; Sébille B
    Sem Hop; 1983 May; 59(18):1413-22. PubMed ID: 6306828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.